BIOMAT Database Logo BIOMAT Database Logo

Acute and chronic toxicity studies of pyribenzamine hydrochloride (N-pyridyl-N-benzyl-N-dimethylethylene diamine HCl. 1946

D MATHIESON, and H W HAYS

UI MeSH Term Description Entries
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D014309 Tripelennamine A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. Azaron,Histantin,Pyribenzamine,Tripelennamine Citrate,Tripelennamine Citrate (1:1),Tripelennamine Hydrochloride,Tripelennamine Maleate,Tripelennamine Maleate (1:1),Tripelennamine Monohydrochloride,Vetibenzamin

Related Publications

D MATHIESON, and H W HAYS
Adrenergic potentiation by pyribenzamine HCl (N-pyridyl N-benzyl-N-dimethylethylenediamine HCl).
January 1946, Federation proceedings,
D MATHIESON, and H W HAYS
Pharmacodynamic studies of a new antihistaminic agent, pyribenzamine (N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylene diamine hydrochloride).
January 1947, The Journal of pharmacology and experimental therapeutics,
D MATHIESON, and H W HAYS
The symptomatic treatment of hay fever with diaminobenzopyridyl HCl (N'-pyridyl-N'-benzyl-N-dimethylethylenediamine hydrochloride)(pyribenzamine).
May 1947, New York state journal of medicine,
D MATHIESON, and H W HAYS
Pyribenzamine (n'-pyridyl-n'-benzyl-n-dimethylethylenediamine HC1), an antagonist of histamine.
July 1946, The Journal of laboratory and clinical medicine,
D MATHIESON, and H W HAYS
Pharmacodynamic studies of a new antihistamine agent, N'-pyridyl-N benzyl-N-dimethylethylene diamine HCI, pyribenzamine HCI; effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure.
July 1946, The Journal of pharmacology and experimental therapeutics,
D MATHIESON, and H W HAYS
Pyribenzamine (N-pyridyl, N-benzyl, dimethyl-ethylenedia-minehydrochloride) in the treatment of allergy.
August 1947, Canadian Medical Association journal,
D MATHIESON, and H W HAYS
[The influence of pyribenzamine (benzyl-alpha-pyridyl-dimethyl-ethylene-diamine) on the blood sugar level].
January 1952, Biochemische Zeitschrift,
D MATHIESON, and H W HAYS
The effect of reduced caloric intake on the toxicity of N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylenediamine monohydrochloride (pyribenzamine).
January 1947, Federation proceedings,
D MATHIESON, and H W HAYS
N,N'-Bis(2-pyridyl)benzene-1,2-diamine.
March 2004, Acta crystallographica. Section C, Crystal structure communications,
D MATHIESON, and H W HAYS
[Acute toxicity studies of propiverine hydrochloride].
October 1989, The Journal of toxicological sciences,
Copied contents to your clipboard!